Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegative”

49 trials

Showing 20 of 49 results

Early research (Phase 1)Study completedNCT02346084
What this trial is testing

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

Who this might be right for
HIV/AIDS
International Partnership for Microbicides, Inc. 19
Not applicableStudy completedNCT02749955
What this trial is testing

Partner Services Pre-exposure Prophylaxis (PS-PrEP)

Who this might be right for
HIV Transmission, Transtheoretical Model of Change
University of Chicago 164
Testing effectiveness (Phase 2)Study completedNCT00434512
What this trial is testing

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

Who this might be right for
AIDSHIV Infections
GlaxoSmithKline 180
Early research (Phase 1)Study completedNCT00955006
What this trial is testing

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00481182
What this trial is testing

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

Who this might be right for
Healthy Subjects
GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT02033109
What this trial is testing

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

Who this might be right for
HIV
Population Council 35
Early research (Phase 1)Study completedNCT00063804
What this trial is testing

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)Study completedNCT01575405
What this trial is testing

Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

Who this might be right for
HIV Prevention
Ian McGowan 13
Post-approval studies (Phase 4)Study completedNCT00648817
What this trial is testing

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Who this might be right for
HIV Infections
Gilead Sciences 8
Early research (Phase 1)Study completedNCT00441909
What this trial is testing

Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT02404805
What this trial is testing

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Who this might be right for
HIVHepatitis C
University of Colorado, Denver 25
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Early research (Phase 1)UnknownNCT00013572
What this trial is testing

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR) 36
Early research (Phase 1)Study completedNCT00961883
What this trial is testing

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 80
Early research (Phase 1)Study completedNCT01386489
What this trial is testing

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

Who this might be right for
HIV NegativeAdaptive ImmunityInnate Immunity
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)WithdrawnNCT03813979
What this trial is testing

Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls.

Who this might be right for
HIV-1-infectionHepatic Impairment
Radboud University Medical Center
Early research (Phase 1)Study completedNCT00408538
What this trial is testing

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

Who this might be right for
HIV Infections
University of California, Los Angeles 36
Not applicableWithdrawnNCT01059084
What this trial is testing

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Who this might be right for
HIVHIV Infections
University of Washington
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation